Literature DB >> 3839484

A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders".

P R Dal Monte, M D'Imperio, M Ferri, F Fratucello, P del Soldato.   

Abstract

Treatment of peptic ulcer in "non-responders" with the combination of pirenzepine and cimetidine was evaluated in a longterm study. Patients who did not respond to two months of treatment, first with cimetidine (1 g/day), and then pirenzepine (150 mg/day), were given one of these two compounds alone for 6 months or a combination at lower doses for 24 months. The combination of pirenzepine (75 mg/day) and cimetidine (400 mg/day) was successful in a high percentage of cases, and showed fewer side effects than in the single treatment groups. The effectiveness of the combination treatment might be due to its more significant anti-secretory effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839484

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Gastric acid secretion stimulated by modified sham-feeding, and the effects of histamine H2-antagonist and anti-muscarinic agent in patients with duodenal ulcer.

Authors:  S Ooi; E Kaneko
Journal:  Gastroenterol Jpn       Date:  1989-10

2.  Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.

Authors:  K D Bardhan; J Naesdal; G Bianchi Porro; M Petrillo; M Lazzaroni; R F Hinchliffe; M Thompson; P Morris; M J Daly; N J Carroll
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

3.  Combined anti-muscarinic and H2 receptor blockade in the healing of refractory duodenal ulcer. A double blind study.

Authors:  K D Bardhan; M Thompson; K Bose; R F Hinchliffe; J Crowe; D G Weir; C McCarthy; J Walters; T J Thomson; M H Thompson
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.